Cargando…
EM-mosaic detects mosaic point mutations that contribute to congenital heart disease
BACKGROUND: The contribution of somatic mosaicism, or genetic mutations arising after oocyte fertilization, to congenital heart disease (CHD) is not well understood. Further, the relationship between mosaicism in blood and cardiovascular tissue has not been determined. METHODS: We developed a new co...
Autores principales: | Hsieh, Alexander, Morton, Sarah U., Willcox, Jon A. L., Gorham, Joshua M., Tai, Angela C., Qi, Hongjian, DePalma, Steven, McKean, David, Griffin, Emily, Manheimer, Kathryn B., Bernstein, Daniel, Kim, Richard W., Newburger, Jane W., Porter, George A., Srivastava, Deepak, Tristani-Firouzi, Martin, Brueckner, Martina, Lifton, Richard P., Goldmuntz, Elizabeth, Gelb, Bruce D., Chung, Wendy K., Seidman, Christine E., Seidman, J. G., Shen, Yufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189690/ https://www.ncbi.nlm.nih.gov/pubmed/32349777 http://dx.doi.org/10.1186/s13073-020-00738-1 |
Ejemplares similares
-
Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease
por: Morton, Sarah U., et al.
Publicado: (2020) -
Rare genetic variation at transcription factor binding sites modulates local DNA methylation profiles
por: Martin-Trujillo, Alejandro, et al.
Publicado: (2020) -
Loss of RNA expression and allele-specific expression associated with congenital heart disease
por: McKean, David M., et al.
Publicado: (2016) -
De Novo Damaging Variants, Clinical Phenotypes, and Post-Operative Outcomes in Congenital Heart Disease
por: Boskovski, Marko T., et al.
Publicado: (2020) -
Genomic analyses implicate noncoding de novo variants in congenital heart disease
por: Richter, Felix, et al.
Publicado: (2020)